SCHEMBL15725468

SCHEMBL15725468

CNC(=O)CCCCCCNC(=O)c1ccc(Nc2nc3ccccc3s2)cc1

nearest known ligand 0.83

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ HDAC6 Q9UBN7 9/20 0.83
▸ HDAC1 Q13547 7/20 0.53
▸ HDAC2 Q92769 4/20 0.53
▸ HDAC8 Q9BY41 2/20 0.51
▸ MAPT P10636 3/20 0.50
▸ HDAC3 O15379 4/20 0.49
▸ CSNK1D P48730 1/20 0.49
▸ HDAC4 P56524 1/20 0.49
▸ HDAC7 Q8WUI4 1/20 0.49
▸ HDAC10 Q969S8 1/20 0.49
▸ HDAC11 Q96DB2 1/20 0.49
▸ HDAC9 Q9UKV0 1/20 0.49
▸ HDAC5 Q9UQL6 1/20 0.49
▸ NPC1 O15118 3/20 0.48
▸ RAB9A P51151 3/20 0.48
▸ SMN1; SMN2 Q16637 3/20 0.48
▸ MEN1 O00255 2/20 0.48
▸ KMT2A Q03164 2/20 0.48
▸ NAMPT P43490 1/20 0.46
▸ CASP3 P42574 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2224465 0.91 HDAC6 (1.00) HDAC6HDAC1HDAC2HDAC8HDAC3
SCHEMBL15725416 0.82 HDAC6 (0.86) HDAC6HDAC1HDAC2HDAC8MAPT
SCHEMBL15725415 0.80 HDAC6 (0.79) HDAC6HDAC1HDAC2HDAC8HDAC3
SCHEMBL8023816 0.79 HDAC6 (0.63) HDAC6MAPTCSNK1DNPC1RAB9A
SCHEMBL15725465 0.78 HDAC6 (0.85) HDAC6HDAC1HDAC2HDAC8HDAC3
SCHEMBL15725410 0.78 HDAC6 (0.83) HDAC6HDAC1HDAC2HDAC8HDAC3
SCHEMBL10447762 0.75 HDAC3 (0.82) HDAC6HDAC1HDAC2HDAC8HDAC3
SCHEMBL24653262 0.75 HDAC1 (0.75) HDAC6HDAC1HDAC2HDAC8HDAC3
SCHEMBL20684933 0.75 HDAC1 (0.75) HDAC6HDAC1HDAC2HDAC8HDAC3
SCHEMBL2226499 0.74 HDAC6 (1.00) HDAC6HDAC1HDAC2HDAC8HDAC3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20140142117-A1 REVERSE AMIDE COMPOUNDS AS PROTEIN DEACETYLASE INHIBITORS AND METHODS OF USE THEREOF ACETYLON PHARMACEUTICALS, INC. 2014-05-22 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20140142117-A1 REVERSE AMIDE COMPOUNDS AS PROTEIN DEACETYLASE INHIBITORS AND METHODS OF USE THEREOF HDAC6, HDAC1, HDAC3 HDAC6 1/4885HDAC1 2/4885HDAC2 7/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback